+499.5%
MRNA vs NBIX
+14.2%
+485.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NBIX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -1.7% | -0.5% | -0.9% |
| 7D | +5.5% | +1.0% | +4.5% | +4.8% |
| 30D | +158.7% | -3.6% | +162.4% | +166.0% |
| 3M | +182.1% | -7.0% | +189.1% | +197.0% |
| 6M | +151.8% | +16.6% | +135.2% | +134.1% |
| YTD | +393.6% | +9.7% | +383.8% | +365.7% |
| 1Y | +499.5% | +10.9% | +488.6% | +465.7% |
| All | +499.5% | +14.2% | +485.3% | +465.7% |
Cumulative growth
Daily Returns
Daily percentage return beside NBIX.
Daily Out/Under-Performance
Portfolio return minus NBIX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NBIX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NBIX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling